screening
House Bill Could Help Employers Dodge GINA
House Bill Could Help Employers Dodge GINA
Joshua A. Krisch | Mar 13, 2017
HR 1313 could circumvent protections offered by the Genetic Information Nondiscrimination Act, enabling employers to incentivize employee sharing of genetic and other medical information.
Targeting the Noncoding Genome with CRISPR
Targeting the Noncoding Genome with CRISPR
Anna Azvolinsky | Sep 29, 2016
Two independent groups demonstrate the utility of CRISPR-based techniques to identify regulatory elements that govern disease-linked genes. 
Targeting Protein Domains with CRISPR
Targeting Protein Domains with CRISPR
Jenny Rood | May 13, 2015
Researchers use the genome-editing tool to mutate binding pockets and identify potential anti-cancer drug targets.
Mining Existing Drugs for Ebola Treatments
Mining Existing Drugs for Ebola Treatments
Rina Shaikh-Lesko | Dec 17, 2014
Researchers hope to repurpose already-approved drugs into potential anti-Ebola therapies.
Culturing Drug-Resistant Tumors
Culturing Drug-Resistant Tumors
Kerry Grens | Nov 17, 2014
Improved methods to grow patients’ tumor cells in a dish offer opportunities to find durable therapies.
Statins Stimulate Bone Growth?
Statins Stimulate Bone Growth?
Kate Yandell | Sep 17, 2014
The cholesterol-lowering drugs could be used to treat people with two types of dwarfism, a study suggests.
A Blood Test for Cancer?
A Blood Test for Cancer?
Beth Marie Mole | Nov 30, 2012
Researchers are getting closer to detecting abnormal tumor DNA circulating in the bloodstream.
Breast Cancer Screening Saves Lives
Breast Cancer Screening Saves Lives
Dan Cossins | Nov 2, 2012
An expert panel finds that the benefits of breast cancer screening outweigh risks that the procedure will lead to unnecessary treatments.
Double-Edged TB Drug
Beth Marie Mole | Sep 12, 2012
A cheap pain reliever that can kill drug-resistant, tuberculosis-causing bacteria may never be tested.
Cancer Test Gets Bad Reviews
Sabrina Richards | May 22, 2012
US Preventive Services Task Force recommends against a commonly used prostate cancer screening.